MLKL and colorectal cancer: In conclusion, we demonstrate for the first time that TRAF6 reduces necroptosis in colorectal cancer cells by directly degrading RIPK1 protein levels and inhibiting the RIPK1-RIPK3-MLKL signaling axis (Fig. 9), resulting in the promotion of tumor progression.